Another study examined the cerebrospinal fluid (CSF) samples taken from patients with Parkinson’s disease, Alzheimer’s disease, and multiple system atrophy and found that complement 3 (C3) and CFH were both increased, though to varying ratios depending upon the disease. This evidence concerns the gene C3 and early-onset autosomal dominant Alzheimer disease.